Clinical Trial Update: A Study to Evaluate the Pharmacokinetics, Safety and Tolerability of Retosiban (GSK221149) When Dosed With Efavirenz (EFZ) [Phase 1]

View source ↗

Summary

Phase 1 study evaluating the pharmacokinetics, safety and tolerability of retosiban when dosed with efavirenz. The trial, sponsored by GlaxoSmithKline for obste…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Preterm Birth
• Preterm Labor

Drugs mentioned

• EFAVIRENZ (efavirenz)
• Retosiban (retosiban)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Obstetric Labour, Premature | Phase 1 | Status: COMPLETED